GLP-1 Medications, Gut Health, and a More Sustainable Path for Women
GLP-1 medications have changed the conversation around weight loss—and for many people, they have been truly life-changing. I want to start there.
These medications can dramatically reduce appetite, improve blood sugar regulation, and offer real relief to people who have struggled for years. For some, they feel nothing short of miraculous. And I deeply respect that.
At the same time, my role as a functional medicine practitioner is to zoom out and ask a different—but complementary—question:
What is happening underneath the surface, particularly in the gut, and how does that shape long-term outcomes for women?
This is where I want to add nuance to the conversation.
A Quick Primer: What Is GLP-1, Really?
GLP-1 (glucagon-like peptide-1) is not a foreign concept to the human body. We are meant to make it.
GLP-1 is a hormone produced primarily in the gut—specifically by specialized cells in the lower small intestine and colon. Its job is to:
Signal fullness to the brain
Slow stomach emptying so we feel satisfied longer
Support balanced blood sugar
Coordinate appetite with nutrient availability
In a healthy system, GLP-1 is released after we eat, especially when food reaches the lower gut and interacts with a diverse, well-functioning gut microbiome.
In other words:
👉 A healthy gut knows how to make GLP-1 naturally.
The Gut Microbiome: The Missing Piece in the GLP-1 Conversation
One of the most overlooked facts about GLP-1 is this:
We don’t produce it efficiently when the gut microbiome is compromised.
When someone has gut health issues—such as low microbial diversity, overgrowth of unfavorable bacteria, inflammation, or impaired digestion—the signaling that triggers GLP-1 release becomes blunted.
In plain terms:
The microbes that help stimulate GLP-1 aren’t thriving
The gut lining isn’t responding properly to food
The hormonal “conversation” between gut and brain breaks down
This is a big reason why my approach to weight loss—especially for women—starts with optimizing gut health, not overriding it.
What I See Clinically in Clients on GLP-1 Medications
When I run comprehensive gut microbiome testing on clients who are actively taking GLP-1 medications, a pattern often emerges.
One common finding is putrefaction.
What Is Putrefaction (in Plain Language)?
Putrefaction occurs when protein sits too long in the digestive tract and is broken down by bacteria in a way that produces harmful byproducts.
GLP-1 medications intentionally slow digestion. While this contributes to appetite suppression, it also means food—especially protein—can linger in the gut longer than intended.
When that happens, certain bacteria begin to:
Ferment protein instead of carbohydrates
Produce compounds like ammonia, phenols, and other toxic metabolites
Increase gut inflammation and burden detox pathways
This doesn’t mean GLP-1 medications are “bad.”
It means they change the digestive environment, and that environment needs support.
Without that support, the gut can quietly become more imbalanced over time.
Why This Matters Even More for Women in Midlife
Hormones and the gut microbiome are deeply interconnected.
As estrogen declines—during perimenopause and menopause—we see predictable shifts in the gut microbiome, including:
Reduced microbial diversity
Loss of bacteria involved in estrogen metabolism (often referred to as the estrobolome)
Increased insulin resistance and inflammation
These changes make it harder to:
Maintain lean muscle
Regulate appetite naturally
Sustain weight loss long-term
This is where I have concerns about relying on appetite suppression alone.
Muscle Loss, Metabolism, and Rebound Weight Gain
Another important consideration with GLP-1 medications is body composition.
Weight loss on the scale does not always mean fat loss alone. Without intentional support, women may lose:
Muscle mass
Metabolic flexibility
Strength and resilience
Muscle is not just about aesthetics—it’s a metabolic organ. It plays a key role in:
Blood sugar regulation
Longevity
Preventing rebound weight gain
When muscle loss occurs and gut health remains unaddressed, stopping GLP-1 medications can lead to rapid weight regain—often with less muscle and more fat than before.
That’s not a failure of the person. It’s a predictable biological response.
My Perspective: Supporting the Body, Not Outsourcing the Signal
I don’t view GLP-1 medications as the enemy.
I view them as a tool—one that can be incredibly helpful when used alongside strategies that restore the body’s ability to regulate appetite, metabolism, and hormones on its own.
This is why my work with women focuses on:
Healing and diversifying the gut microbiome
Improving digestion and nutrient absorption
Supporting estrogen balance and metabolic health
Preserving and building lean muscle
When these foundations are in place, many women find that:
Their natural GLP-1 signaling improves
Hunger cues become more reliable
Weight regulation feels less like a battle
A Gut- and Hormone-Forward Approach to Body Composition
If this resonates, my Women’s Body Composition Program was designed specifically with these principles in mind.
This is not a “quick fix” program. It’s a structured, science-informed approach that prioritizes:
Gut microbiome optimization
Hormone-aware nutrition strategies
Muscle preservation and metabolic health
Sustainable weight loss that works with the body
Whether or not someone is using GLP-1 medications, these foundations matter—and they become even more important in midlife.
Final Thoughts
GLP-1 medications can be powerful.
Gut health is foundational.
Women deserve an approach that respects both.
My goal is never to shame, judge, or take away tools that help people feel better in their bodies. My goal is to help women build resilient systems that support long-term health, confidence, and vitality—on or off medication.
If you’re curious about what your gut and hormones are doing beneath the surface, that’s where I love to begin.
— Liz
